Coronavirus Disease 2019 and Chest CT: Do Not Put the Sensitivity Value in the Isolation Room and Look Beyond the Numbers

MSCCov19Net: multi-branch deep learning model for COVID-19 detection from cough sounds

Coronavirus has an impact on millions of lives and has been added to the important pandemics that continue to affect with its variants. Since it is transmitted through the respiratory tract, it has had significant effects on public health and social relations. Isolating people who are COVID positive can minimize the transmission, therefore several exams are proposed to detect the virus such as reverse transcription-polymerase chain reaction (RT-PCR), chest X-Ray, and computed tomography (CT). However, these methods suffer from either a low detection rate or high radiation dosage, along with being expensive. In this study, deep neural network-based model capable of detecting coronavirus from only coughing sound, which is fast, remotely operable and has no harmful side effects, has been proposed. The proposed multi-branch model takes M el Frequency Cepstral Coefficients (MFCC), S pectrogram, and C hromagram as inputs and is abbreviated as MSCCov19Net. The system is trained on publicly available crowdsourced datasets, and tested on two unseen (used only for testing) clinical and non-clinical datasets. Experimental outcomes represent that the proposed system outperforms the 6 popular deep learning architectures on four datasets by representing a better generalization ability. The proposed system has reached an accuracy of 61.5 % in Virufy and 90.4 % in NoCoCoDa for unseen test datasets.

Cough Audio Analysis for COVID-19 Diagnosis

Humanity has suffered catastrophically due to the COVID-19 pandemic. One of the most reliable diagnoses of COVID-19 is RT-PCR (reverse-transcription polymer chain reaction) testing. This method, however, has its limitations. It is time consuming and requires scalability. This research work carries out a preliminary prognosis of COVID-19, which is scalable and less time consuming. The research carried out a competitive analysis of four machine-learning models namely, Multilayer Perceptron, Convolutional Neural Networks, Recurrent Neural Networks with Long Short-Term Memory, and VGG-19 with Support Vector Machines. Out of these models, Multilayer Perceptron outperformed with higher specificity of 94.5% and accuracy of 96.8%. The results show that Multilayer Perceptron was able to distinguish between positive and negative COVID-19 coughs by a robust feature embedding technique.

Identifying COVID-19 by using spectral analysis of cough recordings: a distinctive classification study

Sound signals from the respiratory system are largely taken as tokens of human health. Early diagnosis of respiratory tract diseases is of great importance because, if delayed, it exerts irreversible effects on human health. The Coronavirus pandemic, which is deeply shaking the world, has revealed the importance of this diagnosis even more. During the pandemic, it has become the focus of researchers to differentiate symptoms from similar diseases such as influenza. Among these symptoms, the difference in cough sound played a distinctive role in research. Clinical data collected under the supervision of doctors in a reliable environment were used as the dataset consisting of 16 subjects suspected of COVID-19 with a specific patient demographic. Using the polymerase chain reaction test, the suspected subjects were divided into two groups as negative and positive. The negative and positive labels represent the patients with non-COVID and with a COVID-19 cough, respectively. Using the 3D plot or waterfall representation of the signal frequency spectrum, the salient features of the cough data are revealed. In this way, COVID-19 can be differentiated from other coughs by applying effective feature extraction and classification techniques. Power spectral density based on short-time Fourier transform and mel-frequency cepstral coefficients (MFCC) were chosen as the efficient feature extraction method. From among the classification techniques, the support vector machine (SVM) algorithm was applied to the processed signals in order to identify and classify COVID-19 cough. In terms of results evaluation, the cough of subjects with COVID-19 was detected with 95.86% classification accuracy thanks to the radial basis function (RBF) kernel function of SVM and the MFCC method. The diagnosis of COVID-19 coughs was performed with 98.6% and 91.7% sensitivity and specificity, respectively.

Deep Learning Based Early Detection Framework for Preliminary Diagnosis of COVID-19 via Onboard Smartphone Sensors

The COVID-19 pandemic has affected almost every country causing devastating economic and social disruption and stretching healthcare systems to the limit. Furthermore, while being the current gold standard, existing test methods including NAAT (Nucleic Acid Amplification Tests), clinical analysis of chest CT (Computer Tomography) scan images, and blood test results, require in-person visits to a hospital which is not an adequate way to control such a highly contagious pandemic. Therefore, top priority must be given, among other things, to enlisting recent and adequate technologies to reduce the adverse impact of this pandemic. Modern smartphones possess a rich variety of embedded MEMS (Micro-Electro-Mechanical-Systems) sensors capable of recording movements, temperature, audio, and video of their carriers. This study leverages the smartphone sensors for the preliminary diagnosis of COVID-19. Deep learning, an important breakthrough in the domain of artificial intelligence in the past decade, has huge potential for extracting apt and appropriate features in healthcare. Motivated from these facts, this paper presents a new framework that leverages advanced machine learning and data analytics techniques for the early detection of coronavirus disease using smartphone embedded sensors. The proposal provides a simple to use and quickly deployable screening tool that can be easily configured with a smartphone. Experimental results indicate that the model can detect positive cases with an overall accuracy of 79% using only the data from the smartphone sensors. This means that the patient can either be isolated or treated immediately to prevent further spread, thereby saving more lives. The proposed approach does not involve any medical tests and is a cost-effective solution that provides robust results.

Imaging in the COVID-19 era: Lessons learned during a pandemic

The first year of the coronavirus disease 2019 (COVID-19) pandemic has been a year of unprecedented changes, scientific breakthroughs, and controversies. The radiology community has not been spared from the challenges imposed on global healthcare systems. Radiology has played a crucial part in tackling this pandemic, either by demonstrating the manifestations of the virus and guiding patient management, or by safely handling the patients and mitigating transmission within the hospital. Major modifications involving all aspects of daily radiology practice have occurred as a result of the pandemic, including workflow alterations, volume reductions, and strict infection control strategies. Despite the ongoing challenges, considerable knowledge has been gained that will guide future innovations. The aim of this review is to provide the latest evidence on the role of imaging in the diagnosis of the multifaceted manifestations of COVID-19, and to discuss the implications of the pandemic on radiology departments globally, including infection control strategies and delays in cancer screening. Lastly, the promising contribution of artificial intelligence in the COVID-19 pandemic is explored.

Diagnostic Performance of CO-RADS and the RSNA Classification System in Evaluating COVID-19 at Chest CT: A Meta-Analysis

PURPOSE

To determine the diagnostic performance of the COVID-19 Reporting and Data System (CO-RADS) and the Radiological Society of North America (RSNA) categorizations in patients with clinically suspected coronavirus disease 2019 (COVID-19) infection.

MATERIALS AND METHODS

In this meta-analysis, studies from 2020, up to August 24, 2020 were assessed for inclusion criteria of studies that used CO-RADS or the RSNA categories for scoring chest CT in patients with suspected COVID-19. A total of 186 studies were identified. After review of abstracts and text, a total of nine studies were included in this study. Patient information (n¸ age, sex), CO-RADS and RSNA scoring categories, and other study characteristics were extracted. Study quality was assessed with the QUADAS-2 tool. Meta-analysis was performed with a random effects model.

RESULTS

Nine studies (3283 patients) were included. Overall study quality was good, except for risk of non-performance of repeated reverse transcriptase polymerase chain reaction (RT-PCR) after negative initial RT-PCR and persistent clinical suspicion in four studies. Pooled COVID-19 frequencies in CO-RADS categories were: 1, 8.8%; 2, 11.1%; 3, 24.6%; 4, 61.9%; and 5, 89.6%. Pooled COVID-19 frequencies in RSNA classification categories were: negative 14.4%; atypical, 5.7%; indeterminate, 44.9%; and typical, 92.5%. Pooled pairs of sensitivity and specificity using CO-RADS thresholds were the following: at least 3, 92.5% (95% CI: 87.1, 95.7) and 69.2% (95%: CI: 60.8, 76.4); at least 4, 85.8% (95% CI: 78.7, 90.9) and 84.6% (95% CI: 79.5, 88.5); and 5, 70.4% (95% CI: 60.2, 78.9) and 93.1% (95% CI: 87.7, 96.2). Pooled pairs of sensitivity and specificity using RSNA classification thresholds for indeterminate were 90.2% (95% CI: 87.5, 92.3) and 75.1% (95% CI: 68.9, 80.4) and for typical were 65.2% (95% CI: 37.0, 85.7) and 94.9% (95% CI: 86.4, 98.2).

CONCLUSION

COVID-19 infection frequency was higher in patients categorized with higher CORADS and RSNA classification categories.

Chest CT in COVID-19: What the Radiologist Needs to Know

Chest CT has a potential role in the diagnosis, detection of complications, and prognostication of coronavirus disease 2019 (COVID-19). Implementation of appropriate precautionary safety measures, chest CT protocol optimization, and a standardized reporting system based on the pulmonary findings in this disease will enhance the clinical utility of chest CT. However, chest CT examinations may lead to both false-negative and false-positive results. Furthermore, the added value of chest CT in diagnostic decision making is dependent on several dynamic variables, most notably available resources (real-time reverse transcription-polymerase chain reaction [RT-PCR] tests, personal protective equipment, CT scanners, hospital and radiology personnel availability, and isolation room capacity) and the prevalence of both COVID-19 and other diseases with overlapping manifestations at chest CT. Chest CT is valuable to detect both alternative diagnoses and complications of COVID-19 (acute respiratory distress syndrome, pulmonary embolism, and heart failure), while its role for prognostication requires further investigation. The authors describe imaging and managing care of patients with COVID-19, with topics including (a) chest CT protocol, (b) chest CT findings of COVID-19 and its complications, (c) the diagnostic accuracy of chest CT and its role in diagnostic decision making and prognostication, and (d) reporting and communicating chest CT findings. The authors also review other specific topics, including the pathophysiology and clinical manifestations of COVID-19, the World Health Organization case definition, the value of performing RT-PCR tests, and the radiology department and personnel impact related to performing chest CT in COVID-19. ©RSNA, 2020.

Patients with Initial Negative RT-PCR and Typical Imaging of COVID-19: Clinical Implications

The sensitivity of reverse transcriptase polymerase chain reaction (RT-PCR) has been questioned due to negative results in some patients who were strongly suspected of having coronavirus disease 2019 (COVID-19). The aim of our study was to analyze the prognosis of infected patients with initial negative RT-PCR in the emergency department (ED) during the COVID-19 outbreak. This study included two cohorts of adult inpatients admitted into the ED. All patients who were suspected to be infected with SARS-CoV-2 and who underwent a typical chest CT imaging were included. Thus, we studied two distinct cohorts: patients with positive RT-PCR (PCR+) and those with negative initial RT-PCR (PCR–). The data were analyzed using Bayesian methods. We included 66 patients in the PCR– group and 198 in the PCR+ group. The baseline characteristics did not differ except in terms of a proportion of lower chronic respiratory disease in the PCR– group. We noted a less severe clinical presentation in the PCR– group (lower respiratory rate, lower oxygen need and mechanical ventilation requirement). Hospital mortality (9.1% vs. 9.6%) did not differ between the two groups. Despite an initially less serious clinical presentation, the mortality of patients infected by SARS-CoV-2 with a negative RT-PCR did not differ from those with positive RT-PCR.

AI4COVID-19: AI enabled preliminary diagnosis for COVID-19 from cough samples via an app

BACKGROUND

The inability to test at scale has become humanity's Achille's heel in the ongoing war against the COVID-19 pandemic. A scalable screening tool would be a game changer. Building on the prior work on cough-based diagnosis of respiratory diseases, we propose, develop and test an Artificial Intelligence (AI)-powered screening solution for COVID-19 infection that is deployable via a smartphone app. The app, named AI4COVID-19 records and sends three 3-s cough sounds to an AI engine running in the cloud, and returns a result within 2 min.

METHODS

Cough is a symptom of over thirty non-COVID-19 related medical conditions. This makes the diagnosis of a COVID-19 infection by cough alone an extremely challenging multidisciplinary problem. We address this problem by investigating the distinctness of pathomorphological alterations in the respiratory system induced by COVID-19 infection when compared to other respiratory infections. To overcome the COVID-19 cough training data shortage we exploit transfer learning. To reduce the misdiagnosis risk stemming from the complex dimensionality of the problem, we leverage a multi-pronged mediator centered risk-averse AI architecture.

RESULTS

Results show AI4COVID-19 can distinguish among COVID-19 coughs and several types of non-COVID-19 coughs. The accuracy is promising enough to encourage a large-scale collection of labeled cough data to gauge the generalization capability of AI4COVID-19. AI4COVID-19 is not a clinical grade testing tool. Instead, it offers a screening tool deployable anytime, anywhere, by anyone. It can also be a clinical decision assistance tool used to channel clinical-testing and treatment to those who need it the most, thereby saving more lives.